Macrocyclic HCV NS3/4A serine protease inhibitors with benzoxaborole at P4 position: Design, synthesis and SAR

被引：0
|
作者：
Zhang, Yong-Kang
Li, Xianfeng
Zhang, Suoming
Liu, Yang
Ding, Charles Z.
Li, Qun
Zhou, Yasheen
Plattner, Jacob J.
Baker, Stephen J.
Feng, Lisa
Liu, Liang
Kazmierski, Wieslaw M.
Duan, Maosheng A.
Ji, Jing-Jing J.
Cooper, Joel P.
Grimes, Richard M.
Tallant, Matthew D.
Wright, Lois L.
Smith, Gary K.
Crosby, Renae M.
Wang, Amy A.
Jarvest, Richard L.
Slater, Martin J.
Edge, Colin M.
Hubbard, Julia A.
Nassau, Pam
McDowell, Bill
Skarzynski, Tadeusz J.
Zou, Wuxin
Dong, Xiantao
Liang, Peng
Xiao, Jianbin
Li, Guanghui
Wang, Shuanghui
Li, Chong
Lu, Gang
Zhao, Baojuan
Zhou, Xinming
Wright, Jon
Ni, Zhi-Jie
Qian, Xuelei
Fan, Dazhong
Liao, Liang
Chen, Dianjun
机构：
[1] Anacor Pharmaceut Inc, Palo Alto, CA USA
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[3] GlaxoSmithKline Inc, Stevenage, Herts, England
[4] BioDuro LLC, Beijing, Peoples R China
[5] Acme Biosci Inc, Palo Alto, CA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 239卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
125-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors
    Naggie, Susanna
    Patel, Keyur
    McHutchison, John
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (10) : 2063 - 2069
  • [22] Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement
    Di Francesco, M. Emilia
    Dessole, Gabriella
    Nizi, Emanuela
    Pace, Paola
    Koch, Uwe
    Fiore, Fabrizio
    Pesci, Silvia
    Di Muzio, Jillian
    Monteagudo, Edith
    Rowley, Michael
    Summa, Vincenzo
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (22) : 7014 - 7028
  • [23] P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profile
    Nair, Latha G.
    Sannigrahi, Mousumi
    Bogen, Stephane
    Pinto, Patrick
    Chen, Kevin X.
    Prongay, Andrew
    Tong, Xiao
    Cheng, K. -C.
    Girijavallabhan, Viyyoor
    Njoroge, F. George
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 567 - 570
  • [24] Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry
    Pillaiyar, Thanigaimalai
    Namasivayam, Vigneshwaran
    Manickam, Manoj
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (29) : 3404 - 3447
  • [25] Hepatitis C virus NS3/4a protease inhibitors
    McCauley, John A.
    Rudd, Michael T.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 84 - 92
  • [26] Bismacrocyclic Inhibitors of Hepatitis C NS3/4a Protease
    McCauley, John A.
    Rudd, Michael T.
    Nguyen, Kevin T.
    McIntyre, Charles J.
    Romano, Joseph J.
    Bush, Kimberly J.
    Varga, Sandor L.
    Ross, Charles W., III
    Carroll, Steven S.
    DiMuzio, Jillian
    Stahlhut, Mark W.
    Olsen, David B.
    Lyle, Terry A.
    Vacca, Joseph P.
    Liverton, Nigel J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (47) : 9104 - 9107
  • [27] Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors
    Shunmugam, Letitia
    Ramharack, Pritika
    Soliman, Mahmoud E. S.
    PROTEIN JOURNAL, 2017, 36 (05): : 397 - 406
  • [28] Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors
    Letitia Shunmugam
    Pritika Ramharack
    Mahmoud E. S. Soliman
    The Protein Journal, 2017, 36 : 397 - 406
  • [29] Solid phase parallel synthesis of alpha-ketoamide inhibitors of NS3•4A HCV Protease.
    Court, JJ
    Cottrell, KC
    Harbeson, SL
    Pitlik, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U18 - U18
  • [30] Prime site binding inhibitors of a serine protease:: NS3/4A of hepatitis C virus
    Ingallinella, P
    Fattori, D
    Altamura, S
    Steinkühler, C
    Koch, U
    Cicero, D
    Bazzo, R
    Cortese, R
    Bianchi, E
    Pessi, A
    BIOCHEMISTRY, 2002, 41 (17) : 5483 - 5492
12345